Angel Yeast (600298) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
Achieved revenue of ¥7.17 billion for H1 2024, up 6.86% year-over-year; net profit attributable to shareholders reached ¥691 million, up 3.21% year-over-year.
Basic EPS was ¥0.80, up 2.56% year-over-year; adjusted EPS (excluding non-recurring items) was ¥0.69, down 2.82% year-over-year.
International business revenue grew 17.89% year-over-year, reaching ¥2.82 billion.
Gross margin and profitability were impacted by higher raw material costs and increased financial expenses.
Financial highlights
Operating cash flow was -¥89 million, down 128.95% year-over-year, mainly due to increased cash outflows for raw material purchases.
Total assets at period end were ¥20.48 billion, up 6.08% from year-end 2023; net assets attributable to shareholders were ¥10.18 billion, up 0.84%.
Gross margin was pressured by a 7.23% increase in cost of sales; financial expenses rose 217.12% due to higher interest costs.
R&D expenses increased 3.97% year-over-year, supporting new product development.
Non-recurring profit items contributed ¥95.15 million, mainly from government subsidies and investment income.
Outlook and guidance
Management remains focused on expanding international markets, product innovation, and cost control to drive future growth.
Ongoing investments in capacity expansion and digital transformation are expected to support long-term competitiveness.
Latest events from Angel Yeast
- Net profit surged 21% in Q3 2025 on higher sales and strong cash flow, despite rising impairments.600298
Q3 202530 Oct 2025 - Q1 2025 delivered double-digit net profit growth and stronger cash flow, despite higher impairments.600298
Q1 202510 Sep 2025 - Double-digit profit and revenue growth achieved, with robust international and product expansion.600298
Q2 202518 Aug 2025 - Q3 2024 revenue surged 27.14% year-over-year, with net profit up 7.02%.600298
Q3 202413 Jun 2025 - Record revenue and profit, with strong global expansion and robust yeast segment growth.600298
Q4 20249 Jun 2025